INVIRAGEN
Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide. Inviragen's lead product is a vaccine to protect against dengue fever, a disease that threatens 2.5 billion people across the globe. Inviragen is also developing a vaccine to protect against West Nile for the North American market, a nasal combination vaccine to protect against both plague and smallpox for biodefense, and a unique vaccine to protect against avian influenza for global markets.
INVIRAGEN
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Fort Collins, Colorado, United States
Country:
United States
Website Url:
http://www.inviragen.com
Total Employee:
11+
Status:
Active
Contact:
9703720693
Email Addresses:
[email protected]
Total Funding:
15 M USD
Technology used in webpage:
IPv6 Google Apps For Business Cloudflare Hosting Cloudflare DNS
Similar Organizations
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Current Advisors List
Investors List
Charter Life Sciences
Charter Life Sciences investment in Series A - Inviragen
EDBI
EDBI investment in Series A - Inviragen
Phillip Private Equity
Phillip Private Equity investment in Series A - Inviragen
Venture Investors
Venture Investors investment in Series A - Inviragen
Official Site Inspections
http://www.inviragen.com
- Host name: 104.21.3.4
- IP address: 104.21.3.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
